ResMed Inc. (ASX:RMD) and these ASX growth shares could be top options for investors this week. Here’s what you need to know about them…
The post 2 buy-rated ASX growth shares for investors this week appeared first on The Motley Fool Australia. –
If you’re a growth investor, then you’re in luck. The local share market is home to a number of top companies that have the potential to grow strongly in the future.
Two top ASX growth shares that have been tipped as buys are listed below. Here’s why they are highly rated:
IDP Education Ltd (ASX: IEL)
IDP Education is a provider of international student placement and English language testing services. While it has been hit hard by the pandemic, it has been tipped to come out of the crisis in an even stronger market position. This could make it a big winner when trading conditions return to normal. Particularly given its investment in software, which appears to have given it another edge over the competition.
Last week analysts at Morgans put an add rating and $28.48 price target on the company’s shares. While the broker acknowledges that the awful COVID-19 outbreak in India is a headwind, it still believes the risk is to the upside for its earnings. This is due to pent-up demand and marger and acquisition opportunities.
ResMed Inc. (ASX: RMD)
Another growth share to look at is ResMed. This sleep treatment-focused medical device company has been growing at a solid rate for a decade. And thanks to its industry-leading products, growing software business, and the increasing awareness of sleep disorders, it looks well-placed to continue this trend over the next 10 years.
Particularly given its long runway for growth. Management estimates that there are ~1 billion people suffering from sleep apnoea worldwide, with only ~20% of these sufferers currently diagnosed. ResMed also appears well-placed to benefit from the shift to home healthcare thanks to its investments in the space.
Credit Suisse is a fan of ResMed. It recently put an outperform rating and $29.00 price target on its shares.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
- 2 buy-rated ASX 200 blue chip shares
- 2 top ASX shares rated as buys this week
- Leading brokers name 3 ASX shares to buy today
- 2 fantastic blue chip ASX 200 shares rated as buys
- What do brokers think of the ResMed (ASX:RMD) share price dip?
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post 2 buy-rated ASX growth shares for investors this week appeared first on The Motley Fool Australia.